Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· October 9, 2026
McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?
View original at finance.yahoo.comMcKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified? McKesson Corporation (NYSE:MCK) is expanding its specialty healthcare operations through a $5.8 billion acquisition (including debt) of Option Care Health, Inc…
O que extraímos desta fonte
The claims Via News extracted from this document. We point to the source; we don't replace it.
McKesson raised its fiscal 2027 adjusted EPS guidance to $44.20-$45.00 from $43.80-$44.60.
60% confidencePrecision Medicine Group is expected to strengthen McKesson's oncology and clinical research capabilities, though the financial payoff from its specialty-care portfolio depends on successful integration.
60% confidence
Citado nestas reportagens da Via News
- Oncology's Busy Autumn: A Cash-Burning Drugmaker Awaits Its Verdict While AI Promises Faster Medicines →
- Oncology's Next Wave Meets Its Test: Summit's Nov. 14 Ivonescimab Decision, a Record Loss, and AI Claims That Are Still Forecasts →
- Oncology's Three Bets: New Drug Types, AI-Built Medicines and a $5.8 Billion Care Deal, and the Cash Behind One Closely Watched Drug →